(Q37392057)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19214609%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

review article

1 reference

title

Dendritic-cell- and peptide-based vaccination strategies for glioma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19214609%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19214609%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

author name string

Ryuya Yamanaka

series ordinal

1

1 reference

20 August 2017

publication date

13 February 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19214609%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19214609%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

volume

32

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19214609%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19214609%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

page(s)

265-73; discussion 273

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19214609%20AND%20SRC:MED&resulttype=core&format=json

Dendritic cell maturation results in pronounced changes in glycan expression affecting recognition by siglecs and galectins

21 January 2020

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10143-009-0189-1

Dendritic cells: immune regulators in health and disease

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10143-009-0189-1

HLA-E protects glioma cells from NKG2D-mediated immune responses in vitro: implications for immune escape in vivo

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10143-009-0189-1

Characterization of Dendritic Cells that Induce Tolerance and T Regulatory 1 Cell Differentiation In Vivo

21 January 2018

1 reference

12 December 2020

Expression of the tumor-rejection antigen SART1 in brain tumors.

1 reference

12 December 2020

Tumor antigen-specific T helper cells in cancer immunity and immunotherapy

1 reference

12 December 2020

Identification of a novel HLA-A*0201-restricted, cytotoxic T lymphocyte epitope in a human glioma-associated antigen, interleukin 13 receptor alpha2 chain

1 reference

12 December 2020

Antitumor vaccination of patients with glioblastoma multiforme: a pilot study to assess feasibility, safety, and clinical benefit.

1 reference

12 December 2020

Tumor antigens in astrocytic gliomas

1 reference

12 December 2020

Vaccination with predesignated or evidence-based peptides for patients with recurrent gynecologic cancers

1 reference

12 December 2020

Sensitization of malignant glioma to chemotherapy through dendritic cell vaccination

1 reference

12 December 2020

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

1 reference

12 December 2020

Increased concentrations of transforming growth factor beta1 and beta2 in the plasma of patients with glioblastoma.

1 reference

12 December 2020

Maturation and trafficking of monocyte-derived dendritic cells in monkeys: implications for dendritic cell-based vaccines

1 reference

12 December 2020

Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration

1 reference

12 December 2020

Isolation of cancer stem cells from adult glioblastoma multiforme

1 reference

12 December 2020

EphA2 as a glioma-associated antigen: a novel target for glioma vaccines

1 reference

12 December 2020

Detection of MAGE-1 tumor antigen in brain tumor.

1 reference

12 December 2020

Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors.

1 reference

12 December 2020

MAGE-E1, a new member of the melanoma-associated antigen gene family and its expression in human glioma.

1 reference

12 December 2020

Cancer immunotherapy: moving beyond current vaccines

1 reference

12 December 2020

Expression of MAGE and GAGE in high-grade brain tumors: a potential target for specific immunotherapy and diagnostic markers.

1 reference

12 December 2020

Surgery and adjuvant dendritic cell-based tumour vaccination for patients with relapsed malignant glioma, a feasibility study

1 reference

12 December 2020

Results of a phase I clinical trial of vaccination of glioma patients with fusions of dendritic and glioma cells.

1 reference

12 December 2020

Expression of cancer testis genes in human brain tumors.

1 reference

12 December 2020

Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas.

1 reference

12 December 2020

Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self

1 reference

12 December 2020

Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma

1 reference

12 December 2020

Immunologic evaluation of personalized peptide vaccination for patients with advanced malignant glioma.

1 reference

12 December 2020

Cytotoxic T cell targeting of TRP-2 sensitizes human malignant glioma to chemotherapy

1 reference

12 December 2020

Maturation of human monocyte-derived dendritic cells studied by microarray hybridization

1 reference

12 December 2020

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

1 reference

12 December 2020

A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening

1 reference

12 December 2020

Humoral responses to peptides correlate with overall survival in advanced cancer patients vaccinated with peptides based on pre-existing, peptide-specific cellular responses.

1 reference

12 December 2020

Antigen-bearing immature dendritic cells induce peptide-specific CD8(+) regulatory T cells in vivo in humans

1 reference

12 December 2020

Expression of the SART3 tumor-rejection antigen in brain tumors and induction of cytotoxic T lymphocytes by its peptides.

1 reference

12 December 2020

Clinical responsiveness of glioblastoma multiforme to chemotherapy after vaccination

1 reference

12 December 2020

Identification of human brain tumour initiating cells

1 reference

12 December 2020

Identification of a human glioma antigen, SOX6, recognized by patients' sera

1 reference

12 December 2020

Clinical evaluation of dendritic cell vaccination for patients with recurrent glioma: results of a clinical phase I/II trial

1 reference

12 December 2020

Dendritic cells: multi-lineal and multi-functional

1 reference

12 December 2020

AIM-2: a novel tumor antigen is expressed and presented by human glioma cells

1 reference

12 December 2020

CD4+FoxP3+ regulatory T cells gradually accumulate in gliomas during tumor growth and efficiently suppress antiglioma immune responses in vivo.

1 reference

12 December 2020

Kinesin superfamily protein-derived peptides with the ability to induce glioma-reactive cytotoxic T lymphocytes in human leukocyte antigen-A24+ glioma patients.

1 reference

12 December 2020

Personalized peptide vaccines: a new therapeutic modality for cancer

1 reference

12 December 2020

Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials

1 reference

12 December 2020

Molecularly targeted therapy for malignant glioma

1 reference

12 December 2020

Vaccination of glioma patients with fusions of dendritic and glioma cells and recombinant human interleukin 12.

1 reference

12 December 2020

Cell lineage and cell migration in the neural crest

1 reference

12 December 2020

Preferential expression and frequent IgG responses of a tumor antigen, SOX5, in glioma patients

1 reference

12 December 2020

A model of human tumor dormancy: an angiogenic switch from the nonangiogenic phenotype

1 reference

12 December 2020

Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line

1 reference

12 December 2020

MGMT gene silencing and benefit from temozolomide in glioblastoma

1 reference

12 December 2020

Vaccination of recurrent glioma patients with tumour lysate-pulsed dendritic cells elicits immune responses: results of a clinical phase I/II trial

1 reference

12 December 2020

Maturation of dendritic cells is a prerequisite for inducing immune responses in advanced melanoma patients

1 reference

12 December 2020

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

12 December 2020

Phase II clinical trial of Wilms tumor 1 peptide vaccination for patients with recurrent glioblastoma multiforme

1 reference

12 December 2020

Direct isolation of human central nervous system stem cells

1 reference

12 December 2020

Induction of cellular immune responses to tumor cells and peptides in colorectal cancer patients by vaccination with SART3 peptides

1 reference

12 December 2020

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

1 reference

12 December 2020

10.1007/S10143-009-0189-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19214609%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference